Graham M. Mead

Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: EORTC Study 30986

Maria De Santis, Joaquim Bellmunt, Graham M. Mead et al. · Journal of Clinical Oncology · 2011 · 773 citations · Full text

Medicine, Oncology, Pharmacology +13

Randomized Phase III Study Comparing Paclitaxel/Cisplatin/ Gemcitabine and Gemcitabine/Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Cancer Without Prior Systemic Therapy: EORTC Intergroup Study 30987

Joaquim Bellmunt, Hans von der Maase, Graham M. Mead et al. · Journal of Clinical Oncology · 2012 · 535 citations · Full text

Medicine, Oncology, Pharmacology +12

Equivalence of Three or Four Cycles of Bleomycin, Etoposide, and Cisplatin Chemotherapy and of a 3- or 5-Day Schedule in Good-Prognosis Germ Cell Cancer: A Randomized Study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council

Ronald de Wit, J.T. Roberts, P M Wilkinson et al. · Journal of Clinical Oncology · 2001 · 366 citations

Medicine, Oncology, Pharmacology +13

Enteropathy-Type Intestinal T-Cell Lymphoma: Clinical Features and Treatment of 31 Patients in a Single Center

Joanna Gale, P.D. Simmonds, Graham M. Mead et al. · Journal of Clinical Oncology · 2000 · 353 citations

Medicine, Oncology, Pathology +14

An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt’s lymphoma: results of United Kingdom Lymphoma Group LY06 study

Graham M. Mead, Matthew R. Sydes, Jan Walewski et al. · Annals of Oncology · 2002 · 336 citations

Medicine, Hematology, Oncology +7